Search research articles
Contact Us
Filters
Showing results (321-330 of 350) with videos related to
Page
of 35
Sort By:
The Lancet. Infectious Diseases
|
March 6, 2019
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, et al.
Advances in Therapy
|
October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis
Markus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Cell Genomics
|
December 7, 2022
Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
Bowen Zhang, Zhenhua Zhang, Valerie A C M Koeken, et al.
Nature Immunology
|
January 14, 2026
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID
Saumya Kumar, Chaofan Li, Liang Zhou, et al.
Gut
|
April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection
Paulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
The Lancet. Infectious Diseases
|
September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 27, 2025
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney
Avista Wahid, Nele Meyer, Christine Wundes, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
April 16, 2023
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
Florian van Bömmel, Kerstin Stein, Renate Heyne, et al.
Gastroenterology
|
February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8<sup>+</sup> T Cells and Evolve at the Population Level
Hadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 350) with videos related to
Sort By:
Page
of 35
The Lancet. Infectious Diseases
|
March 6, 2019
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, et al.
Advances in Therapy
|
October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis
Markus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Cell Genomics
|
December 7, 2022
Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
Bowen Zhang, Zhenhua Zhang, Valerie A C M Koeken, et al.
Nature Immunology
|
January 14, 2026
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID
Saumya Kumar, Chaofan Li, Liang Zhou, et al.
Gut
|
April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection
Paulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
The Lancet. Infectious Diseases
|
September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 27, 2025
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney
Avista Wahid, Nele Meyer, Christine Wundes, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
April 16, 2023
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
Florian van Bömmel, Kerstin Stein, Renate Heyne, et al.
Gastroenterology
|
February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8<sup>+</sup> T Cells and Evolve at the Population Level
Hadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.
Page
of 35